Stay updated on AK104 Plus Anlotinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the AK104 Plus Anlotinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK104 Plus Anlotinib in NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The study record history shows a new revision entry for v3.6.3 and the previous v3.6.2 is removed. This reflects an update to the page's revision metadata.
    Difference
    0.1%
    Check dated 2026-07-03T21:47:03.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A new version entry v3.6.2 was added to the study record history, and the previous version v3.6.0 was removed, updating the version history for the study.
    Difference
    0.1%
    Check dated 2026-06-26T19:43:26.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Recruitment is now closed for participants. A new revision (v3.6.0) has been added and the previous revision (v3.5.5) removed.
    Difference
    0.4%
    Check dated 2026-06-12T11:41:07.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The Record History adds a new release entry showing Revision: v3.5.5, replacing the previous Revision: v3.5.4. This reflects an administrative update to the page's versioning and release notes.
    Difference
    0.1%
    Check dated 2026-06-05T08:10:53.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    There are no additions or deletions recorded for this study history in the provided data.
    Difference
    0.1%
    Check dated 2026-05-21T22:38:36.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.5.4' was added to the Record History, indicating the study record has been updated to a newer version in the history log.
    Difference
    0.2%
    Check dated 2026-05-14T22:17:04.000Z thumbnail image

Stay in the know with updates to AK104 Plus Anlotinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK104 Plus Anlotinib in NSCLC Clinical Trial page.